Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Moodys
Cantor Fitzgerald
AstraZeneca
Cerilliant
Merck
Medtronic
Dow

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE

« Back to Dashboard

Clinical Trials for Ethosuximide

Trial ID Title Status Sponsor Phase Summary
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status Children's Hospital Medical Center, Cincinnati Phase 3 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Phase 2 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Health Center Phase 2 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT01122381 Comparison of a Drug and Placebo in the Prevention of Migraine Headaches Terminated Thomas Jefferson University Phase 1/Phase 2 The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
NCT01122381 Comparison of a Drug and Placebo in the Prevention of Migraine Headaches Terminated University of Pittsburgh Phase 1/Phase 2 The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
NCT01122381 Comparison of a Drug and Placebo in the Prevention of Migraine Headaches Terminated VA Office of Research and Development Phase 1/Phase 2 The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ethosuximide

Condition Name

Condition Name for Ethosuximide
Intervention Trials
Epilepsy 2
Headache, Migraine 1
Seizures 1
Petit Mal Epilepsy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ethosuximide
Intervention Trials
Syndrome 2
Epilepsy 2
Somatoform Disorders 1
Irritable Bowel Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ethosuximide

Trials by Country

Trials by Country for Ethosuximide
Location Trials
United States 23
United Kingdom 3
France 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ethosuximide
Location Trials
Pennsylvania 2
Illinois 1
Arizona 1
Arkansas 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ethosuximide

Clinical Trial Phase

Clinical Trial Phase for Ethosuximide
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ethosuximide
Clinical Trial Phase Trials
Recruiting 2
Terminated 2
Completed 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ethosuximide

Sponsor Name

Sponsor Name for Ethosuximide
Sponsor Trials
University Hospital, Clermont-Ferrand 2
National Institute for Health Research, United Kingdom 1
VA Office of Research and Development 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ethosuximide
Sponsor Trials
Other 22
U.S. Fed 1
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Chinese Patent Office
Boehringer Ingelheim
Cipla
McKinsey
Julphar
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.